International Conference onPharmaceutical Sciences and Drug Delivery
Early Bird Registration End Date: Feb 05, 2025
Abstract Submission Opens: Oct 25, 2024
Potential Exhibitor
Sciconx proffers our immense pleasure and honor in extending you a warm invitation to attend our Conferences. It is focusing on "BRIDGING THE GAP BETWEEN ACADEMIA AND INDUSTRY" to enhance and explore knowledge among Life Science community and Industrial Community to establish corporations and exchanging ideas. Providing the right stage to present stimulating Keynote talks, Plenary sessions, Discussion Panels, B2B Meetings, Poster symposia, Video Presentations and Workshops.
We hope you will join us for a symphony of outstanding experience, and take a little extra time to enjoy the spectacular and unique beauty of this region.
Our Target Audiences
Academic Professionals
Students
Industrial Delegates
Exhibitor Benefits & Packages
An opportunity to sponsor one poster presentation award.
Complimentary conference registration.
Set up of one tailor-made exhibit booth (Booth Size 3x3 sqm).
Logo recognition on conference website sponsorship page.
A4 Color Advertisement in conference Proceedings.
Inclusion of your company’s Flyer/Logo in the conference delegate bags.
Exclusive online promotion on all our social Networking Sites.
Promote your corporate image through logo branding.
Brand briefing at the opening and closing ceremonies.
Senores Pharmaceuticals IPO fully subscribed within hours on opening day; check price band, lot size and key dates
2024-12-20 - 2024-12
Senores Pharmaceuticals IPO has received a strong response from investors, as the initial public offer was fully-subscribed within hours on opening day. Till 1:55 pm, it was booked 1.01 times.
According to the consolidated data on the NSE website, the initial share sale received bids for 86,41,390 shares against 85,34,681 equity shares on offer.
Retail investors oversubscribed 4.32 times, as they placed bids for 66,80,058 shares compared to 15,46,586 shares on offer. The portion for non-institutional investors was subscribed 81% as they subscribed to 18,70,512 shares against 23,19,879 shares on offer.